Prostaglandin E(2) pathway in head and neck squamous cell carcinoma

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Prostaglandin E(2) (PGE(2)) plays a role in malignant growth.
• Understanding the PGE(2) pathway in head and neck squamous cell carcinoma (HNSCC) is crucial.

Purpose of the Study:

• To investigate the expression of key enzymes and receptors within the PGE(2) pathway in HNSCC patients.
• To identify potential therapeutic targets for HNSCC treatment.

Main Methods:

• Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was used to analyze gene expression.
• Biopsies from 83 HNSCC patients were examined.
• Expression levels of cyclooxygenase (COX) isoenzymes, PGE-synthase, and PGE-receptors were quantified.

Main Results:

• Significant overexpression of COX-2 (4-fold) and cytosolic-PGE-synthase (2.5-fold) was observed in HNSCC tumors compared to paired normal tissue.
• EP-1 was the only significantly overexpressed PGE-receptor in tumor samples.
• Expression of COX-1 correlated with mPGES-2, and COX-2 correlated with mPGES-1.

Conclusions:

• COX-2, in coordination with mPGES-1, appears to be the rate-limiting enzyme in PGE(2) biosynthesis in HNSCC.
• mPGES-1, cPGES, and EP-1 represent potential targets for novel HNSCC therapeutics.
• Targeting these molecules may offer an alternative to COX-2 selective inhibitors, potentially avoiding negative side effects.